Rates of aldosterone antagonist use after myocardial infarction remain poor over time among guideline eligible patients

Houman Khalili, Anthony G Edwards, Jacqueline Jones, James A de Lemos, Sandeep R Das

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1334-1335
Number of pages2
JournalInternational Journal of Cardiology
Issue number3
StatePublished - Oct 20 2014


  • ACS
  • Aldosterone antagonist
  • Guideline adherence
  • Guidelines
  • Myocardial infarction
  • Quality improvement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this